{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T17:00:41Z","timestamp":1792083641364,"version":"4.4.0"},"reference-count":83,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","theclinics.com","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pediatric Clinics of North America"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.pcl.2018.04.005","type":"journal-article","created":{"date-parts":[[2018,7,19]],"date-time":"2018-07-19T19:23:40Z","timestamp":1532028220000},"page":"691-709","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":132,"title":["Systemic Juvenile Idiopathic Arthritis"],"prefix":"10.1016","volume":"65","author":[{"given":"Jennifer J.Y.","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rayfel","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.pcl.2018.04.005_bib1","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.3899\/jrheum.120661","article-title":"Incidence and prevalence of juvenile idiopathic arthritis among children in a managed care population, 1996-2009","volume":"40","author":"Harrold","year":"2013","journal-title":"J\u00a0Rheumatol"},{"issue":"9783","key":"10.1016\/j.pcl.2018.04.005_bib2","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1016\/S0140-6736(11)60244-4","article-title":"Juvenile idiopathic arthritis","volume":"377","author":"Prakken","year":"2011","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.pcl.2018.04.005_bib3","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1093\/rheumatology\/keh710","article-title":"Does systemic-onset juvenile idiopathic arthritis belong under juvenile idiopathic arthritis?","volume":"44","author":"Ramanan","year":"2005","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"10.1016\/j.pcl.2018.04.005_bib4","first-page":"343","article-title":"Evaluation of the presentation of systemic onset juvenile rheumatoid arthritis: data from the Pennsylvania systemic onset juvenile arthritis registry (PASOJAR)","volume":"35","author":"Behrens","year":"2008","journal-title":"J\u00a0Rheumatol"},{"issue":"2","key":"10.1016\/j.pcl.2018.04.005_bib5","first-page":"390","article-title":"International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001","volume":"31","author":"Petty","year":"2004","journal-title":"J\u00a0Rheumatol"},{"issue":"2","key":"10.1016\/j.pcl.2018.04.005_bib6","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.1442-200X.1997.tb03593.x","article-title":"Clinical analysis of 570 cases with juvenile rheumatoid arthritis: results of a nationwide retrospective survey in Japan","volume":"39","author":"Fujikawa","year":"1997","journal-title":"Acta Paediatr Jpn"},{"issue":"3","key":"10.1016\/j.pcl.2018.04.005_bib7","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/BF02751521","article-title":"Clinico-immunological profile in juvenile rheumatoid arthritis\u2013an Indian experience","volume":"63","author":"Seth","year":"1996","journal-title":"Indian J Pediatr"},{"issue":"2","key":"10.1016\/j.pcl.2018.04.005_bib8","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1136\/ard.30.2.121","article-title":"Still's disease in the adult","volume":"30","author":"Bywaters","year":"1971","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.pcl.2018.04.005_bib9","first-page":"424","article-title":"Preliminary criteria for classification of adult Still's disease","volume":"19","author":"Yamaguchi","year":"1992","journal-title":"J\u00a0Rheumatol"},{"issue":"3","key":"10.1016\/j.pcl.2018.04.005_bib10","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1097\/00005792-200205000-00003","article-title":"Proposal for a new set of classification criteria for adult-onset still disease","volume":"81","author":"Fautrel","year":"2002","journal-title":"Medicine (Baltimore)"},{"issue":"9","key":"10.1016\/j.pcl.2018.04.005_bib11","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.3899\/jrheum.150997","article-title":"The systemic juvenile idiopathic arthritis cohort of the childhood arthritis and rheumatology research alliance registry: 2010-2013","volume":"43","author":"Janow","year":"2016","journal-title":"J\u00a0Rheumatol"},{"issue":"7","key":"10.1016\/j.pcl.2018.04.005_bib12","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1002\/acr.21625","article-title":"Consensus treatment plans for new-onset systemic juvenile idiopathic arthritis","volume":"64","author":"DeWitt","year":"2012","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"3","key":"10.1016\/j.pcl.2018.04.005_bib13","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/0049-0172(76)90027-5","article-title":"Juvenile rheumatoid arthritis: a general review and report of 100 patients observed for 15 years","volume":"5","author":"Calabro","year":"1976","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.pcl.2018.04.005_bib14","doi-asserted-by":"crossref","unstructured":"Schneider R, Laxer RM. Chapter 3: systemic juvenile idiopathic arthritis. In: Cimaz R, Lehman T, editors. Handbook of systemic autoimmune diseases, vol. 6. Elsevier BV; 2007. p.\u00a035\u2013274.","DOI":"10.1016\/S1571-5078(07)06007-2"},{"key":"10.1016\/j.pcl.2018.04.005_bib15","doi-asserted-by":"crossref","first-page":"271569","DOI":"10.1155\/2012\/271569","article-title":"Systemic arthritis in children: a review of clinical presentation and treatment","volume":"2012","author":"Gurion","year":"2012","journal-title":"Int J Inflam"},{"issue":"5","key":"10.1016\/j.pcl.2018.04.005_bib16","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S0022-3476(68)80003-4","article-title":"Rash associated with juvenile rheumatoid arthritis","volume":"72","author":"Calabro","year":"1968","journal-title":"J\u00a0Pediatr"},{"issue":"99","key":"10.1016\/j.pcl.2018.04.005_bib17","first-page":"377","article-title":"The rash of rheumatoid arthritis and Still's disease","volume":"25","author":"Bywaters","year":"1956","journal-title":"Q\u00a0J Med"},{"issue":"1","key":"10.1016\/j.pcl.2018.04.005_bib18","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1546-0096-7-11","article-title":"The temporomandibular joint in juvenile idiopathic arthritis: frequently used and frequently arthritic","volume":"7","author":"Ringold","year":"2009","journal-title":"Pediatr Rheumatol Online J"},{"key":"10.1016\/j.pcl.2018.04.005_bib19","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1136\/ard.31.5.364","article-title":"Cervical spine involvement in patients with chronic arthritis undergoing orthopaedic surgery","volume":"31","author":"Ornilla","year":"1972","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.pcl.2018.04.005_bib20","first-page":"211","article-title":"Systemic onset juvenile chronic arthritis, polyarticular pattern and hip involvement as markers for a bad prognosis","volume":"19","author":"Modesto","year":"2001","journal-title":"Clin Exp Rheumatol"},{"issue":"12","key":"10.1016\/j.pcl.2018.04.005_bib21","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1093\/rheumatology\/41.12.1428","article-title":"Long-term follow-up of 246 adults with juvenile idiopathic arthritis: functional outcome","volume":"41","author":"Packham","year":"2002","journal-title":"Rheumatology"},{"issue":"3","key":"10.1016\/j.pcl.2018.04.005_bib22","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1053\/berh.2002.0233","article-title":"Long-term outcomes and predictors of outcomes for patients with juvenile idiopathic arthritis","volume":"16","author":"Oen","year":"2002","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"5","key":"10.1016\/j.pcl.2018.04.005_bib23","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1212\/WNL.54.5.1203","article-title":"Still\u2019s disease can cause neutrophilic meningitis","volume":"54","author":"Blockmans","year":"2000","journal-title":"Neurology"},{"issue":"12","key":"10.1016\/j.pcl.2018.04.005_bib24","first-page":"2429","article-title":"Nasal septal perforation: a novel clinical manifestation of systemic juvenile idiopathic arthritis\/adult onset Still's disease","volume":"32","author":"Avcin","year":"2005","journal-title":"J\u00a0Rheumatol"},{"issue":"5","key":"10.1016\/j.pcl.2018.04.005_bib25","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1002\/acr.21889","article-title":"Pulmonary hypertension and other potentially fatal pulmonary complications in systemic juvenile idiopathic arthritis","volume":"65","author":"Kimura","year":"2013","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"5","key":"10.1016\/j.pcl.2018.04.005_bib26","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1097\/00002281-200309000-00011","article-title":"Macrophage activation syndrome and reactive hemophagocytic lymphohistiocytosis: the same entities?","volume":"15","author":"Grom","year":"2003","journal-title":"Curr Opin Rheumatol"},{"issue":"5","key":"10.1016\/j.pcl.2018.04.005_bib27","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1136\/adc.85.5.421","article-title":"Macrophage activation syndrome: a potentially fatal complication of rheumatic disorders","volume":"85","author":"Sawhney","year":"2001","journal-title":"Arch Dis Child"},{"issue":"5","key":"10.1016\/j.pcl.2018.04.005_bib28","first-page":"1133","article-title":"Occult macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis","volume":"34","author":"Behrens","year":"2007","journal-title":"J\u00a0Rheumatol"},{"issue":"3","key":"10.1016\/j.pcl.2018.04.005_bib29","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1093\/rheumatology\/kep418","article-title":"Mutations in the perforin gene can be linked to macrophage activation syndrome in patients with systemic onset juvenile idiopathic arthritis","volume":"49","author":"Vastert","year":"2010","journal-title":"Rheumatology"},{"issue":"2","key":"10.1016\/j.pcl.2018.04.005_bib30","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/art.23199","article-title":"Mutations of the hemophagocytic lymphohistiocytosis-associated gene UNC13D in a patient with systemic juvenile idiopathic arthritis","volume":"58","author":"Hazen","year":"2008","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.pcl.2018.04.005_bib31","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.berh.2014.03.002","article-title":"Macrophage activation syndrome and cytokine directed therapies","volume":"28","author":"Schulert","year":"2014","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"4","key":"10.1016\/j.pcl.2018.04.005_bib32","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/gene.2012.3","article-title":"Macrophage activation syndrome as part of systemic juvenile idiopathic arthritis: diagnosis, genetics, pathophysiology and treatment","volume":"13","author":"Ravelli","year":"2012","journal-title":"Genes Immun"},{"key":"10.1016\/j.pcl.2018.04.005_bib33","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1146\/annurev-med-061813-012806","article-title":"Pathogenesis of macrophage activation syndrome and potential for cytokine-directed therapies","volume":"66","author":"Schulert","year":"2015","journal-title":"Annu Rev Med"},{"issue":"1","key":"10.1016\/j.pcl.2018.04.005_bib34","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1309\/AJCPMD5TJEFOOVBW","article-title":"Marrow assessment for hemophagocytic lymphohistiocytosis demonstrates poor correlation with disease probability","volume":"141","author":"Ho","year":"2014","journal-title":"Am J Clin Pathol"},{"issue":"3","key":"10.1016\/j.pcl.2018.04.005_bib35","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1136\/annrheumdis-2015-208982","volume":"75","author":"Ravelli","year":"2016","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"10.1016\/j.pcl.2018.04.005_bib36","doi-asserted-by":"crossref","first-page":"3160","DOI":"10.1002\/art.38802","article-title":"Clinical features, treatment, and outcome of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: a multinational, multicenter study of 362 patients","volume":"66","author":"Minoia","year":"2014","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"10.1016\/j.pcl.2018.04.005_bib37","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0022-3476(99)70372-0","article-title":"Malignancies in children who initially present with rheumatic complaints","volume":"134","author":"Cabral","year":"1999","journal-title":"J\u00a0Pediatr"},{"issue":"1","key":"10.1016\/j.pcl.2018.04.005_bib38","first-page":"53","article-title":"Microcytic anaemia in juvenile chronic arthritis","volume":"16","author":"Harvey","year":"1987","journal-title":"Scand J Rheumatol"},{"issue":"12","key":"10.1016\/j.pcl.2018.04.005_bib39","doi-asserted-by":"crossref","first-page":"3924","DOI":"10.1002\/art.24137","article-title":"S100A12 is a novel molecular marker differentiating systemic-onset juvenile idiopathic arthritis from other causes of fever of unknown origin","volume":"58","author":"Wittkowski","year":"2008","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.pcl.2018.04.005_bib40","first-page":"431","article-title":"Juvenile chronic arthritis in a Turkish population","volume":"9","author":"Ozdogan","year":"1991","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"10.1016\/j.pcl.2018.04.005_bib41","first-page":"168","article-title":"Radiologic features of systemic onset juvenile rheumatoid arthritis","volume":"22","author":"Lang","year":"1995","journal-title":"J\u00a0Rheumatol"},{"issue":"10","key":"10.1016\/j.pcl.2018.04.005_bib42","first-page":"1665","article-title":"Discrimination of acute lymphoblastic leukemia from systemic-onset juvenile idiopathic arthritis at disease onset","volume":"66","author":"Tamashiro","year":"2011","journal-title":"Clinics (Sao Paulo)"},{"issue":"8","key":"10.1016\/j.pcl.2018.04.005_bib43","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1002\/1097-0142(19850415)55:8<1637::AID-CNCR2820550804>3.0.CO;2-H","article-title":"The adverse effect of prolonged prednisolone pretreatment in children with acute lymphoblastic leukemia","volume":"55","author":"Revesz","year":"1985","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.pcl.2018.04.005_bib44","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S0022-3476(96)70115-4","article-title":"Seasonal onset of systemic-onset juvenile rheumatoid arthritis","volume":"129","author":"Feldman","year":"1996","journal-title":"J\u00a0Pediatr"},{"issue":"7","key":"10.1016\/j.pcl.2018.04.005_bib45","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1038\/nrrheum.2011.68","article-title":"Pathogenesis of systemic juvenile idiopathic arthritis: some answers, more questions","volume":"7","author":"Mellins","year":"2011","journal-title":"Nat Rev Rheumatol"},{"issue":"9","key":"10.1016\/j.pcl.2018.04.005_bib46","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1084\/jem.20050473","article-title":"Role of interleukin-1 (IL-1) in the pathogenesis of systemic onset juvenile idiopathic arthritis and clinical response to IL-1 blockade","volume":"201","author":"Pascual","year":"2005","journal-title":"J\u00a0Exp Med"},{"issue":"3","key":"10.1016\/j.pcl.2018.04.005_bib47","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1002\/art.20944","article-title":"Therapeutic efficacy of humanized recombinant anti-interleukin-6 receptor antibody in children with systemic-onset juvenile idiopathic arthritis","volume":"52","author":"Yokota","year":"2005","journal-title":"Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.pcl.2018.04.005_bib48","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1002\/art.23437","article-title":"The pattern of response to anti-interleukin-1 treatment distinguishes two subsets of patients with systemic-onset juvenile idiopathic arthritis","volume":"58","author":"Gattorno","year":"2008","journal-title":"Arthritis Rheum"},{"issue":"52","key":"10.1016\/j.pcl.2018.04.005_bib49","doi-asserted-by":"crossref","first-page":"15970","DOI":"10.1073\/pnas.1520779112","article-title":"HLA-DRB1*11 and variants of the MHC class II locus are strong risk factors for systemic juvenile idiopathic arthritis","volume":"112","author":"Ombrello","year":"2015","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"issue":"10","key":"10.1016\/j.pcl.2018.04.005_bib50","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1002\/art.38092","volume":"65","author":"Ringold","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.pcl.2018.04.005_bib51","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1186\/s13075-017-1462-2","article-title":"Experience with etanercept, tocilizumab, and interleukin-1 inhibitors in systemic onset juvenile idiopathic arthritis patients from the BIKER registry","volume":"19","author":"Horneff","year":"2017","journal-title":"Arthritis Res Ther"},{"issue":"10","key":"10.1016\/j.pcl.2018.04.005_bib52","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1136\/annrheumdis-2014-205372","article-title":"The outcomes of juvenile idiopathic arthritis in children managed with contemporary treatments: results from the ReACCh-Out cohort","volume":"74","author":"Guzman","year":"2015","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"10.1016\/j.pcl.2018.04.005_bib53","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1136\/ard.2010.134254","article-title":"A\u00a0multicentre, randomised, double-blind, placebo-controlled trial with the interleukin-1 receptor antagonist anakinra in patients with systemic-onset juvenile idiopathic arthritis (ANAJIS trial)","volume":"70","author":"Quartier","year":"2011","journal-title":"Ann Rheum Dis"},{"issue":"25","key":"10.1016\/j.pcl.2018.04.005_bib54","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1056\/NEJMoa1205099","article-title":"Two randomized trials of canakinumab in systemic juvenile idiopathic arthritis","volume":"367","author":"Ruperto","year":"2012","journal-title":"N\u00a0Engl J Med"},{"issue":"9","key":"10.1016\/j.pcl.2018.04.005_bib55","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1002\/art.38699","article-title":"Randomized, double-blind, placebo-controlled trial of the efficacy and safety of rilonacept in the treatment of systemic juvenile idiopathic arthritis","volume":"66","author":"Ilowite","year":"2014","journal-title":"Arthritis Rheumatol"},{"issue":"9617","key":"10.1016\/j.pcl.2018.04.005_bib56","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/S0140-6736(08)60454-7","article-title":"Efficacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled, withdrawal phase III trial","volume":"371","author":"Yokota","year":"2008","journal-title":"Lancet"},{"issue":"25","key":"10.1016\/j.pcl.2018.04.005_bib57","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1056\/NEJMoa1112802","article-title":"Randomized trial of tocilizumab in systemic juvenile idiopathic arthritis","volume":"367","author":"De Benedetti","year":"2012","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.pcl.2018.04.005_bib58","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/ajh.1141","article-title":"Hyperferritinemia as indicator for intravenous immunoglobulin treatment in reactive macrophage activation syndromes","volume":"68","author":"Emmenegger","year":"2001","journal-title":"Am J Hematol"},{"issue":"5","key":"10.1016\/j.pcl.2018.04.005_bib59","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/S0022-3476(96)70160-9","article-title":"Efficacy of cyclosporine A in the treatment of macrophage activation syndrome in juvenile arthritis: report of five cases","volume":"129","author":"Mouy","year":"1996","journal-title":"J\u00a0Pediatr"},{"issue":"2","key":"10.1016\/j.pcl.2018.04.005_bib60","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1097\/CCM.0000000000001402","article-title":"Interleukin-1 receptor blockade is associated with reduced mortality in sepsis patients with features of the macrophage activation syndrome: re-analysis of a prior phase III trial","volume":"44","author":"Shakoory","year":"2016","journal-title":"Crit Care Med"},{"key":"10.1016\/j.pcl.2018.04.005_bib61","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/nrrheum.2015.179","article-title":"Macrophage activation syndrome in the era of biologic therapy","volume":"12","author":"Grom","year":"2016","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.pcl.2018.04.005_bib62","series-title":"Handbook of growth and growth monitoring in health and disease","first-page":"1959","article-title":"Growth in Juvenile idiopathic arthritis","author":"Erguven","year":"2012"},{"issue":"1","key":"10.1016\/j.pcl.2018.04.005_bib63","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s12969-017-0196-7","article-title":"Growth and weight gain in children with juvenile idiopathic arthritis: results from the ReACCh-Out cohort","volume":"15","author":"Guzman","year":"2017","journal-title":"Pediatr Rheumatol Online J"},{"issue":"6","key":"10.1016\/j.pcl.2018.04.005_bib64","first-page":"1296","article-title":"Linear growth and final height in patients with systemic juvenile idiopathic arthritis treated with long-term glucocorticoids","volume":"29","author":"Simon","year":"2002","journal-title":"J\u00a0Rheumatol"},{"issue":"3","key":"10.1016\/j.pcl.2018.04.005_bib65","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1002\/art.38984","article-title":"Catch-up growth during tocilizumab therapy for systemic juvenile idiopathic arthritis: results from a phase III trial","volume":"67","author":"De Benedetti","year":"2015","journal-title":"Arthritis Rheumatol"},{"issue":"2","key":"10.1016\/j.pcl.2018.04.005_bib66","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1542\/peds.92.2.295","article-title":"American Academy of Pediatrics Section on Rheumatology and Section on Ophthalmology: guidelines for ophthalmologic examinations in children with juvenile rheumatoid arthritis","volume":"92","year":"1993","journal-title":"Pediatrics"},{"issue":"2","key":"10.1016\/j.pcl.2018.04.005_bib67","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/art.21852","article-title":"Health-related quality of life in adolescents with juvenile idiopathic arthritis","volume":"55","author":"Shaw","year":"2006","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.pcl.2018.04.005_bib68","doi-asserted-by":"crossref","first-page":"e0153267","DOI":"10.1371\/journal.pone.0153267","article-title":"Long-term health-related quality of life in German patients with juvenile idiopathic arthritis in comparison to German general population","volume":"11","author":"Barth","year":"2016","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.pcl.2018.04.005_bib69","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1093\/rheumatology\/kel218","article-title":"Health-related quality of life of patients with juvenile idiopathic arthritis coming from 3 different geographic areas. The PRINTO multinational quality of life cohort study","volume":"46","author":"Gutierrez-Suarez","year":"2007","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"10.1016\/j.pcl.2018.04.005_bib70","first-page":"491","article-title":"Systemic onset juvenile idiopathic arthritis: a retrospective study of 80 consecutive patients followed for 10 years","volume":"27","author":"Lomater","year":"2000","journal-title":"J\u00a0Rheumatol"},{"issue":"5","key":"10.1016\/j.pcl.2018.04.005_bib71","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1002\/art.21774","article-title":"Predictors of disease course and remission in systemic juvenile idiopathic arthritis: significance of early clinical and laboratory features","volume":"54","author":"Singh-Grewal","year":"2006","journal-title":"Arthritis Rheum"},{"issue":"9","key":"10.1016\/j.pcl.2018.04.005_bib72","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1136\/annrheumdis-2012-201388","article-title":"It is time to rethink juvenile idiopathic arthritis classification and nomenclature","volume":"71","author":"Martini","year":"2012","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.pcl.2018.04.005_bib73","first-page":"394","article-title":"Health status of patients with juvenile rheumatoid arthritis at 1 and 5 years after diagnosis","volume":"30","author":"Bowyer","year":"2003","journal-title":"J\u00a0Rheumatol"},{"issue":"3","key":"10.1016\/j.pcl.2018.04.005_bib74","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1002\/art.10863","article-title":"Outcome in adults with juvenile idiopathic arthritis: a quality of life study","volume":"48","author":"Foster","year":"2003","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.pcl.2018.04.005_bib75","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1002\/art.38615","article-title":"Review: is there a window of opportunity for treatment of systemic juvenile idiopathic arthritis?","volume":"66","author":"Nigrovic","year":"2014","journal-title":"Arthritis Rheumatol"},{"issue":"11","key":"10.1016\/j.pcl.2018.04.005_bib76","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1002\/1529-0131(200011)43:11<2402::AID-ANR5>3.0.CO;2-C","article-title":"Early predictors of poor functional outcome in systemic-onset juvenile rheumatoid arthritis: a multicenter cohort study","volume":"43","author":"Spiegel","year":"2000","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.pcl.2018.04.005_bib77","doi-asserted-by":"crossref","first-page":"329","DOI":"10.3899\/jrheum.120386","article-title":"Patients with very early-onset systemic juvenile idiopathic arthritis exhibit more inflammatory features and a worse outcome","volume":"40","author":"Russo","year":"2013","journal-title":"J\u00a0Rheumatol"},{"issue":"2","key":"10.1016\/j.pcl.2018.04.005_bib78","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1002\/art.27218","article-title":"Mortality outcomes in pediatric rheumatology in the US","volume":"62","author":"Hashkes","year":"2010","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.pcl.2018.04.005_bib79","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/BF00442095","article-title":"Prognosis in juvenile chronic arthritis. Follow-up of 433 chronic rheumatic children","volume":"135","author":"Stoeber","year":"1981","journal-title":"Eur J Pediatr"},{"issue":"3","key":"10.1016\/j.pcl.2018.04.005_bib80","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1002\/1529-0131(200103)44:3<523::AID-ANR99>3.0.CO;2-1","article-title":"Increased mortality in adults with a history of juvenile rheumatoid arthritis: a population-based study","volume":"44","author":"French","year":"2001","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.pcl.2018.04.005_bib81","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/S0889-857X(21)00134-4","article-title":"Juvenile rheumatoid arthritis: outcome and treatment for the 1990s","volume":"17","author":"Wallace","year":"1991","journal-title":"Rheum Dis Clin North Am"},{"issue":"Suppl 2","key":"10.1016\/j.pcl.2018.04.005_bib82","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1136\/annrheumdis-2017-eular.5005","article-title":"THU0076 disease-modifying treatment regimens have been insufficient to reduce the incidence of systemic aa amyloidosis associated with rheumatoid arthritis in contrast to a significant reduction in those with juvenile idiopathic arthritis","volume":"76","author":"Youngstein","year":"2017","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"10.1016\/j.pcl.2018.04.005_bib83","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1080\/03009740701340339","article-title":"Why can we no longer find juvenile idiopathic arthritis-associated amyloidosis in childhood or in adolescence in Finland?","volume":"36","author":"Immonen","year":"2007","journal-title":"Scand J Rheumatol"}],"container-title":["Pediatric Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031395518300440?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031395518300440?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,5]],"date-time":"2025-07-05T18:25:02Z","timestamp":1751739902000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031395518300440"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":83,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["S0031395518300440"],"URL":"https:\/\/doi.org\/10.1016\/j.pcl.2018.04.005","relation":{},"ISSN":["0031-3955"],"issn-type":[{"value":"0031-3955","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Systemic Juvenile Idiopathic Arthritis","name":"articletitle","label":"Article Title"},{"value":"Pediatric Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pcl.2018.04.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2018 Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}